Department of Cardiology, Children's Hospital of Soochow University, Suzhou, Jiangsu, 215003, China.
Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou, Jiangsu, 215003, China.
Pediatr Res. 2023 Sep;94(3):1125-1135. doi: 10.1038/s41390-023-02558-6. Epub 2023 Mar 24.
The prediction model of intravenous immunoglobulin (IVIG) resistance in Kawasaki disease can calculate the probability of IVIG resistance and provide a basis for clinical decision-making. We aim to assess the quality of these models developed in the children with Kawasaki disease.
Studies of prediction models for IVIG-resistant Kawasaki disease were identified through searches in the PubMed, Web of Science, and Embase databases. Two investigators independently performed literature screening, data extraction, quality evaluation, and discrepancies were settled by a statistician. The checklist for critical appraisal and data extraction for systematic reviews of prediction modeling studies (CHARMS) was used for data extraction, and the prediction models were evaluated using the Prediction Model Risk of Bias Assessment Tool (PROBAST).
Seventeen studies meeting the selection criteria were included in the qualitative analysis. The top three predictors were neutrophil measurements (peripheral neutrophil count and neutrophil %), serum albumin level, and C-reactive protein (CRP) level. The reported area under the curve (AUC) values for the developed models ranged from 0.672 (95% confidence interval [CI]: 0.631-0.712) to 0.891 (95% CI: 0.837-0.945); The studies showed a high risk of bias (ROB) for modeling techniques, yielding a high overall ROB.
IVIG resistance models for Kawasaki disease showed high ROB. An emphasis on improving their quality can provide high-quality evidence for clinical practice.
This study systematically evaluated the risk of bias (ROB) of existing prediction models for intravenous immunoglobulin (IVIG) resistance in Kawasaki disease to provide guidance for future model development meeting clinical expectations. This is the first study to systematically evaluate the ROB of IVIG resistance in Kawasaki disease by using PROBAST. ROB may reduce model performance in different populations. Future prediction models should account for this problem, and PROBAST can help improve the methodological quality and applicability of prediction model development.
川崎病静脉注射免疫球蛋白(IVIG)耐药的预测模型可以计算 IVIG 耐药的概率,为临床决策提供依据。我们旨在评估这些针对川崎病儿童开发的模型的质量。
通过在 PubMed、Web of Science 和 Embase 数据库中搜索,确定了预测川崎病 IVIG 耐药的模型研究。两名研究者独立进行文献筛选、数据提取、质量评估,由统计学家解决分歧。使用系统评价中预测模型风险偏倚评估工具(PROBAST)对预测模型进行评估。
符合选择标准的 17 项研究纳入定性分析。前三个预测因子是中性粒细胞测量值(外周血中性粒细胞计数和中性粒细胞%)、血清白蛋白水平和 C 反应蛋白(CRP)水平。所开发模型的报告曲线下面积(AUC)值范围为 0.672(95%置信区间[CI]:0.631-0.712)至 0.891(95% CI:0.837-0.945);研究在建模技术方面存在高偏倚风险(ROB),整体 ROB 较高。
川崎病 IVIG 耐药模型存在高 ROB。强调提高其质量可以为临床实践提供高质量的证据。
本研究系统评估了现有的川崎病 IVIG 耐药预测模型的偏倚风险(ROB),为未来满足临床预期的模型开发提供指导。这是第一项使用 PROBAST 系统评估川崎病 IVIG 耐药的 ROB 的研究。ROB 可能会降低不同人群中模型的性能。未来的预测模型应考虑到这一问题,而 PROBAST 可以帮助提高预测模型开发的方法学质量和适用性。